Ranbaxy Laboratories Ltd has informed BSE that:
'In response to media reports pointing to USFDA website that Ranbaxy has received an Import Alert for its Mohali facility in India, we would like to inform you that the Company has so far not received any communication from the USFDA on this subject. We are seeking information from the USFDA in this regard.'
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
